- Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
-
Nogami A, Yoneda M, Iwaki M, Kobayashi T, Honda Y, Ogawa Y, Imajo K, Saito S, Nakajima A
- KMID: 2539795
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S123-S135.
- doi: 10.3350/cmh.2022.0357
Non-alcoholic fatty liver disease is currently the most common chronic liver disease, affecting up to 25% of the global population. Simple fatty liver, in which fat is deposited in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis
-
Kumada T, Toyoda H, Ogawa S, Gotoh T, Suzuki Y, Imajo K, Sugimoto K, Kakegawa T, Kuroda H, Yasui Y, Tamaki N, Kurosaki M, Izumi N, Akita T, Tanaka J, Nakajima A
- KMID: 2552902
- Ultrasonography.
- 2024 Mar;43(2):121-131.
- doi: 10.14366/usg.23194
Purpose: The effect of hepatic fibrosis stage on quantitative ultrasound based on the attenuation coefficient (AC) for liver lipid quantification is controversial. The objective of this study was to determine... -
- CITED
-
- Close
- SHARE
-
- Close
